Tervuursesteenweg 244, 3001 Leuven
By providing clinicians with standardized measurements on their patients’ brain MRI scans, icometrix aims to improve personalized care of patients with a neurological disorder. Based on decades of experience in brain MRI analysis of the universities of Antwerp and Leuven, icometrix developed reliable automated MRI biomarkers. Starting from a clinical scan, which is already acquired regularly in routine clinical practice, they provide an easy interpretable report to the clinician, including population graphs and statistics that can be used to follow-up individual patients. For people with Multiple Sclerosis (MS), icometrix developed MSmetrix, which detects brain lesions, calculates lesion volume and measures the whole brain and grey matter volume and atrophy. When combined with the qualitative radiological report, automated measurements will play a crucial role in the transition to more evidence-based follow-up of disease progression and treatment decision-making. icometrix’s software-as-a-service is also incorporated in clinical trials and large research studies regarding Traumatic Brain Injury (TBI), Epilepsy, Alzheimer’s Disease, Stroke, etc.